胺碘酮联合厄贝沙坦对心力衰竭合并心律失常的疗效及机制研究.doc

***碘***联合厄贝沙坦对心力衰竭合并心律失常的疗效及机制研究
覃启高
广西柳钢医院
X
关注成功!
加关注后您将方便地在我的关注中得到本文献的被引频次变化的通知!
新浪微博
腾讯微博
人人网
开心网
豆瓣网
网易微博
摘    要:
目的观察***碘***联合厄贝沙坦对心力衰竭合并心律失常的临床疗效, 探讨其作用机制。方法 91例心力衰竭合并心律失常患者作为研究对象, 以随机分组的方式分为观察组(46例) 和对照组(45例) 。对照组使用常规治疗联合***碘***, 观察组在对照组基础上加用厄贝沙坦, 对比两组窦性心律维持率及治疗效果。%%, 差异具有统计学意义(P<) 。观察组治疗后第1、3、%、%、%%、%、%, 差异具有统计学意义(P<) 。治疗前两组心输出量(CO) 、左室射血分数(LVEF) 、左心室收缩末期内径(LVESD) 、左心室舒张末期内径(LVEDD) 比较差异无统计学意义(P>) ;治疗后两组CO、LVEF、LVESD、LVEDD均优于治疗前, 且观察组明显优于对照组, 差异具有统计学意义(P<) 。%%, 差异具有统计学意义(P<) 。结论在治疗心力衰竭合并心律失常中应用***碘***联合厄贝沙坦比单一方式效果更好, 可有效改善患者窦性心律维持率, 值得临床推广应用。
关键词:
***碘***; 厄贝沙坦; 心力衰竭合并心律失常; 疗效;
Study on the efficacy and mechanism of bined with irbesartan on heart plicated with arrhythmia
QIN Qi-gao
Guangxi Liugang Hospital;
Abstract:
Objective To observe the clinical efficacy of bined with irbesartan on heart plicated with arrhythmia, and discuss its mechanism of action. Methods A total of 91 heart plicated with arrhythmia patients as study subjects were divided by random grouping method into observation group (46 cases) and control group (45 cases) . The control group received conventional therapy and amiodarone, and the observation group received irbesartan on the basis of the control group. Comparison were made on sinus rhythm maintenance rate and treatment